mannuronic acid has been researched along with Alloxan Diabetes in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alizadeh, S; Javanbakht, MH; Mirshafiey, A; Mortazavi-Jahromi, SS | 2 |
| Brotzu, G; Cappai, A; Congiu, T; De Seta, W; Dessy, E; Petruzzo, P; Ruiu, G; Santa Cruz, G | 1 |
3 other study(ies) available for mannuronic acid and Alloxan Diabetes
| Article | Year |
|---|---|
Cardioprotective effect of β-d-mannuronic acid (M2000) as a novel NSAID on gene expression of oxLDL scavenger receptors in the experimental diabetic model.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Aorta; Cardiotonic Agents; CD36 Antigens; Diabetes Mellitus, Experimental; Gene Expression Regulation; Hexuronic Acids; Male; Rats; Rats, Sprague-Dawley; Scavenger Receptors, Class A; Scavenger Receptors, Class E | 2018 |
Anti-diabetic effect of
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Biomarkers; Blood Glucose; Diabetes Mellitus, Experimental; Disease Models, Animal; Fasting; Hexuronic Acids; Hypoglycemic Agents; Immunosuppressive Agents; Inflammation; Insulin; Male; Rats; Rats, Sprague-Dawley | 2019 |
Evaluation of new small barium alginate microcapsules.
Topics: Alginates; Animals; Biocompatible Materials; Capsules; Cell Survival; Cell Transplantation; Diabetes Mellitus, Experimental; Drug Carriers; Erythrocytes; Glucuronic Acid; Hexuronic Acids; Humans; Hyperglycemia; Insulin; Islets of Langerhans; Microscopy, Electron; Microscopy, Electron, Scanning; Microspheres; Oxygen; Rats; Rats, Wistar; Swine; Uronic Acids | 1995 |